Elizabeth Whalley Buono will be presenting Scaling the Health Economy at the “Virginia Impact Summit” hosted by the Office of Governor Northam, the Virginia Impact Investing Forum & Social Entrepreneurship… Read more »
August 23, 2018 The Medicare Advantage sector is experiencing steady growth. From the increasing number of enrolled beneficiaries, to health insurers investing in this privatized version of traditional Medicare, to… Read more »
August 21, 2018 Unlike the regulatory prohibitions against drug and device manufacturers advertising and/or promoting use of their products off-label, doctors are free to responsibly use FDA-regulated products outside of… Read more »
August 13, 2018 The U.S. Department of Health and Human Services (HHS), Office of Inspector General (OIG) released a new report this month highlighting its concern with the enormous increase… Read more »
August 8, 2018 On September 5, 2018, the Virginia Board of Medicine’s (“BOM”) “Licensure by Endorsement” regulations will become effective. These regulations, published in the Virginia Register on August 8,… Read more »
July 30, 2018 As part of its new series of monthly updates entitled “4-1-1 on Survey Enhancements” the Joint Commission has identified sterile medication compounding as its first high-risk area… Read more »
July 25, 2018 A Florida federal district court has held that Tampa General Hospital’s declaratory judgment action against the Secretary of the Department of Health and Human Services can proceed. … Read more »
July 2, 2018 An Illinois hospital has successfully appealed a trial court order requiring it to produce confidential and privileged Patient Safety Work Product (“PSWP”) documents and finding it in… Read more »
Navigating compliance requirements in a space co-regulated at both the federal and state level can be complex and challenging. Recent changes in how the Virginia Board of Pharmacy classifies investigational… Read more »
THE OPIOID CRISIS RESPONSE ACT OF 2018: POTENTIAL HEALTHCARE IMPLICATIONS Elizabeth Whalley Buono, a Director at Hancock, Daniel & Johnson, P.C. (Hancock Daniel), has been serving as an expert panel… Read more »
